Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy.

Autor: Firdessa-Fite R; Columbia Center for Translational Immunology, Department of Medicine and Naomi Berrie Diabetes Center, Columbia University Irving Medical Center, New York, NY, United States., Johnson SN; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States., Bechi Genzano C; Columbia Center for Translational Immunology, Department of Medicine and Naomi Berrie Diabetes Center, Columbia University Irving Medical Center, New York, NY, United States., Leon MA; Department of Chemistry, University of Kansas, Lawrence, KS, United States., Ku A; Department of Pathology and Cell Biology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, United States., Ocampo Gonzalez FA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, United States., Milner JD; Department of Pediatrics, Division of Allergy and Immunology, Columbia University Irving Medical Center, New York, NY, United States., Sestak JO; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States., Berkland C; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, KS, United States., Creusot RJ; Columbia Center for Translational Immunology, Department of Medicine and Naomi Berrie Diabetes Center, Columbia University Irving Medical Center, New York, NY, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jun 12; Vol. 15, pp. 1258369. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).